Lake Street Keeps Their Buy Rating on REPRO-MED Systems (KRMD)
Lake Street analyst Frank Takkinen reiterated a Buy rating on REPRO-MED Systems (KRMD – Research Report) today and set a price target of $6.00.
KORU Medical Systems, Inc. (NASDAQ:KRMD) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript March 12, 2025 Operator: Greetings. And welcome to the KORU Medical Systems’ Fourth Quarter ...
REPRO-MED Systems (KRMD) Receives a Hold from Piper Sandler
Piper Sandler analyst Jason Bednar maintained a Hold rating on REPRO-MED Systems (KRMD – Research Report) today and set a price target of ...
KORU Medical Systems Inc (KRMD) Q4 2024 Earnings Call Highlights: Record Revenues and Strategic ...
KORU Medical Systems Inc (KRMD) reports a 23% revenue increase and expands its international footprint, while addressing challenges in the immunoglobulin market.
KORU Medical Systems (KRMD) to Release Earnings on Wednesday
KORU Medical Systems (NASDAQ:KRMD – Get Free Report) is expected to issue its quarterly earnings data after the market closes on Wednesday, March 12th. Analysts expect the company to announce earnings ...